Trials / Conditions / Resected Pancreatic Adenocarcinoma
Resected Pancreatic Adenocarcinoma
4 registered clinical trials studyying Resected Pancreatic Adenocarcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) NCT07252232 | Revolution Medicines, Inc. | Phase 3 |
| Recruiting | Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following NCT07044453 | University Hospital, Rouen | Phase 2 / Phase 3 |
| Completed | Study of Proton Therapy in Adjuvant Pancreatic Cancer NCT03885284 | Georgetown University | Phase 1 |
| Unknown | Hyperthermia European Adjuvant Trial NCT01077427 | Klinikum der Universitaet Muenchen, Grosshadern | Phase 3 |